|
SCARB2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.277000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.500000E-01 |
| Normal-vs-Stage2 |
6.261000E-01 |
| Normal-vs-Stage3 |
6.539400E-01 |
| Normal-vs-Stage4 |
8.555400E-01 |
| Stage1-vs-Stage2 |
2.937800E-01 |
| Stage1-vs-Stage3 |
7.952000E-01 |
| Stage1-vs-Stage4 |
6.284400E-01 |
| Stage2-vs-Stage3 |
4.691600E-01 |
| Stage2-vs-Stage4 |
9.756200E-01 |
| Stage3-vs-Stage4 |
6.614400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.091600E-01 |
| Normal-vs-AfricanAmerican |
9.012000E-01 |
| Normal-vs-Asian |
9.699800E-01 |
| Caucasian-vs-AfricanAmerican |
6.936200E-01 |
| Caucasian-vs-Asian |
8.995800E-01 |
| AfricanAmerican-vs-Asian |
9.934800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.137500E-02 |
| Normal-vs-Female |
3.106000E-02 |
| Male-vs-Female |
2.194400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.486000E-01 |
| Normal-vs-Extreme_Weight |
1.050580E-01 |
| Normal-vs-Obese |
6.270600E-01 |
| Normal-vs-Extreme_Obese |
8.666400E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.760600E-01 |
| Normal_Weight-vs-Obese |
9.368400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.851200E-01 |
| Extreme_Weight-vs-Obese |
3.380600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.700800E-01 |
| Obese-vs-Extreme_Obese |
3.670400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.857000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.925600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.082300E-02 |
| Normal-vs-Age(81-100Yrs) |
5.788400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.826200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.107000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.776000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.393600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.987000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.940200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.952200E-01 |
| Normal-VS-Type2 PRCC |
7.610000E-02 |
| Normal-VS-KIRP CIMP |
6.460400E-02 |
| Normal-VS-Unclassified PRCC |
2.976000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.717000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.482300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.882500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.578300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.187700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.878200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.352200E-02 |
| Normal-vs-N1 |
8.623600E-01 |
| Normal-vs-N2 |
5.523200E-01 |
| N0-vs-N1 |
2.170800E-01 |
| N0-vs-N2 |
4.037000E-01 |
| N1-vs-N2 |
4.501600E-01 |
|
|
